Literature DB >> 20091428

Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation.

Ryuma Shineha1, Masahiro Kawakami, Koji Kawakami, Motohiko Nagata, Takashi Tada, Kazuto Kato.   

Abstract

The lack of knowledge of current public attitudes towards basic research into induced pluripotent stem cells (iPSCs) is a serious problem when considering appropriate ways of governance regarding research and its clinical applications. We therefore conducted an internet-based survey to determine public opinion regarding the research and development of iPSCs and regenerative medicine (RM). A total of 14,908 valid responses were collected, which revealed that the Japanese public were familiar with the terms iPSCs and RM, and many of them had received information about iPSCs and RM through the television and newspapers. They also generally accepted the need for extra funding for research into iPSCs, but also decided to adopt a "wait and see" approach and thought that research and development of iPSCs and RM should be conducted under proper governance in accordance with an international regulatory framework. It will be necessary to discuss an internationally consistent regulatory system and effective mechanisms for information flow.

Mesh:

Year:  2010        PMID: 20091428     DOI: 10.1007/s12015-009-9111-z

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  7 in total

1.  Communication. Social values and the governance of science.

Authors:  George Gaskell; Edna Einsiedel; William Hallman; Susanna Hornig Priest; Jonathan Jackson; Johannus Olsthoorn
Journal:  Science       Date:  2005-12-23       Impact factor: 47.728

2.  Science communication. Interactions with the mass media.

Authors:  Hans Peter Peters; Dominique Brossard; Suzanne de Cheveigné; Sharon Dunwoody; Monika Kallfass; Steve Miller; Shoji Tsuchida
Journal:  Science       Date:  2008-07-11       Impact factor: 47.728

3.  Overview of the clinical application of regenerative medicine products in Japan.

Authors:  Mina Tsubouchi; Shigeyuki Matsui; Yoshiro Banno; Kiyoshi Kurokawa; Koji Kawakami
Journal:  Health Policy       Date:  2008-04-18       Impact factor: 2.980

4.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 6.  Diversity in public views toward stem cell sources and policies.

Authors:  Edna Einsiedel; Shainur Premji; Rose Geransar; Noelle C Orton; Thushaanthini Thavaratnam; Laura K Bennett
Journal:  Stem Cell Rev Rep       Date:  2009-04-22       Impact factor: 5.739

7.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069

  7 in total
  9 in total

Review 1.  The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

2.  Fantasies about stem cell therapy in chronic ischemic stroke patients.

Authors:  Young Seo Kim; Dan-Il Chung; Hojin Choi; Wonki Baek; Hyun Young Kim; Sung Hyuk Heo; Dae-Il Chang; Hae Ri Na; Seung Hyun Kim; Seong-Ho Koh
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

Review 3.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

4.  A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - A pilot study.

Authors:  Ryuma Shineha; Yusuke Inoue; Yoshimi Yashiro
Journal:  Regen Ther       Date:  2022-05-13       Impact factor: 3.651

5.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

6.  Analysis of the Expectation of Stem Cell Therapy in Patients with Alzheimer's Disease.

Authors:  Seokgil Han; Hojin Choi; Young Seo Kim; Kyu-Yong Lee; Young Joo Lee; Seong-Ho Koh
Journal:  Dement Neurocogn Disord       Date:  2016-12-31

Review 7.  Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.

Authors:  Kayo Takashima; Michael Morrison; Jusaku Minari
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

8.  A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.

Authors:  Ryuma Shineha; Yusuke Inoue; Tsunakuni Ikka; Atsuo Kishimoto; Yoshimi Yashiro
Journal:  Stem Cells Transl Med       Date:  2018-01-26       Impact factor: 6.940

9.  Science communication in regenerative medicine: Implications for the role of academic society and science policy.

Authors:  Ryuma Shineha; Yusuke Inoue; Tsunakuni Ikka; Atsuo Kishimoto; Yoshimi Yashiro
Journal:  Regen Ther       Date:  2017-12-06       Impact factor: 3.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.